The extracellular vesicles in HIV infection and progression: mechanisms, and theranostic implications
- PMID: 38655385
- PMCID: PMC11035885
- DOI: 10.3389/fbioe.2024.1376455
The extracellular vesicles in HIV infection and progression: mechanisms, and theranostic implications
Abstract
Extracellular vesicles (EVs), these minute yet mighty cellular messengers are redefining our understanding of a spectrum of diseases, from cancer to cardiovascular ailments, neurodegenerative disorders, and even infectious diseases like HIV. Central to cellular communication, EVs emerge as both potent facilitators and insightful biomarkers in immune response and the trajectory of disease progression. This review ventures deep into the realm of EVs in HIV-unraveling their pivotal roles in diagnosis, disease mechanism unravelling, and therapeutic innovation. With a focus on HIV, we will highlights the transformative potential of EVs in both diagnosing and treating this formidable virus. Unveiling the intricate dance between EVs and HIV, the review aims to shed light on novel therapeutic strategies that could significantly benefit HIV therapy, potentially even leading to the eradication of HIV.
Keywords: HIV; extracellular vesicles; infection; mechanisms; progression.
Copyright © 2024 Tang, Lu, Dong, Wu and Li.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures





References
-
- Arenaccio C., Chiozzini C., Columba-Cabezas S., Manfredi F., Affabris E., Baur A., et al. (2014). Exosomes from human immunodeficiency virus type 1 (HIV-1)-Infected cells license quiescent CD4 + T lymphocytes to replicate HIV-1 through a Nef- and ADAM17-dependent mechanism. J. Virol. 88 (19), 11529–11539. 10.1128/jvi.01712-14 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Miscellaneous